Table 1 Demographic and clinical features of AAAD+ patients and AAAD− individuals.
Training set(n = 55) | Validation set(n = 122) | P-value3 (AAAD+ in Training vs. validation | |||||
|---|---|---|---|---|---|---|---|
AAAD+ (n = 25) | AAAD− (n = 30) | P-value1 (AAAD+ vs. AAAD−) | AAAD+ (n = 64) | AAAD− (n = 58) | P-value2 (AAAD+ vs. AAAD−) | ||
Age (years) | 51.20 ± 12.50 | 51.47 ± 6.45 | 0.919a | 51.25 ± 12.52 | 51.19 ± 6.16 | 0.974a | 0.987a |
Female | 13 | 10 | 0.162b | 18 | 20 | 0.134b | 0.342b |
Smoker | 2 | 0 | 0.202b | 9 | 0 | 0.003b | 0.721b |
Alcohol abuse | 1 | 0 | 0.455b | 6 | 0 | 0.029b | 0.668b |
Hypertension | 15 | 15 | 0.458b | 44 | 29 | 0.035b | 0.433b |
Hyperlipidemia | 15 | 5 | 0.001b | 38 | 10 | <0.001b | 0.957b |
Atherosclerosis | 0 | 0 | — | 0 | 0 | — | — |
Aortic aneurysm | 1 | 0 | 0.455b | 2 | 0 | 0.175b | 0.837b |
Marfan’s syndrome | 1 | 0 | 0.455b | 4 | 0 | 0.053b | 0.679b |
Bicuspid aortic valve | 0 | 0 | — | 0 | 0 | — | — |
Cocaine abuse | 0 | 0 | — | 0 | 0 | — | — |
Diabetes | 0 | 0 | — | 9 | 1 | 0.018b | 0.057b |
Previous AD | 2 | 0 | 0.202b | 6 | 0 | 0.029b | 0.838b |
